IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: A meta-analysis

Epidemiology and Infection

Volumn 143, Issue 14, 2015, Pages 2975-2984

  Xuan, Y ^a   Wang, L N ^a   Li, W ^b   Zi, H R ^a   Guo, Y ^a   Yan, W J ^a   Chen, X B ^a   Wei, P M ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b NANJING MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

IFITM3; influenza; meta analysis; polymorphism

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; ASIAN; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNICITY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; IFITM3 GENE; INFECTION RISK; INFECTION SENSITIVITY; INFLUENZA; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

IFITM3 PROTEIN, HUMAN; MEMBRANE PROTEIN; RNA BINDING PROTEIN;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLUENZA, HUMAN; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RNA-BINDING PROTEINS; YOUNG ADULT;

EID: 84944060501     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268815000278     Document Type: Article

References (25)

1. Fineberg HV. Pandemic preparedness and response - lessons from the H1N1 influenza of 2009. New England Journal of Medicine 2014; 370: 1335-1342.
2. Ginsberg J, et al. Detecting influenza epidemics using search engine query data. Nature 2009; 457: 1012-1014.
3. Zhang YH, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nature Communications 2013; 4: 1418.
4. Wang Z, et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proceedings of the National Academy of Sciences USA 2014; 111: 769-774.
5. Horby P, et al. An updated systematic review of the role of host genetics in susceptibility to influenza. Influenza and Other Respiratory Viruses 2013; 7 (Suppl. 2): 37-41.
6. Horby P, et al. The role of host genetics in susceptibility to influenza: a systematic review. PLoS ONE 2012; 7: e33180.
7. Horby P, et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiology and Infection 2010; 138: 1550-1558.
8. Brass AL, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009; 139: 1243-1254.
9. Jia R, et al. The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. Journal of Virology 2012; 86: 13697-13707.
10. Everitt AR, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012; 484: 519-523.
11. Mills TC, et al. IFITM3 and susceptibility to respiratory viral infections in the community. Journal of Infectious Diseases 2014; 209: 1028-1031.
12. Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. British Medical Journal 2009; 339: b2535.
13. Wells OCB, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2006 (www.ohri.ca/programs/clinical-epidemiology/oxford.htm).
14. Higgins JP, et al. Measuring inconsistency in metaanalyses. British Medical Journal 2003; 327: 557-560.
15. Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Statistics in Medicine 2012; 31: 3805-3820.
16. Der Simonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7: 177-188.
17. Egger M, et al. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997; 315: 629-634.
18. Peters JL, et al. Comparison of two methods to detect publication bias in meta-analysis. Journal of the American Medical Association 2006; 295: 676-680.
19. Gao HN, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. New England Journal of Medicine 2013; 368: 2277-2285.
20. Bautista E, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. New England Journal of Medicine 2010; 362: 1708-1719.
21. Husain M. Avian influenza A (H7N9) virus infection in humans: Epidemiology, evolution, and pathogenesis. Journal of Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases 2014; 28c: 304-312.
22. Gao R, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. New England Journal of Medicine 2013; 368: 1888-1897.
23. Wang D, et al. Genetic tuning of the novel avian influenza A(H7N9) virus during interspecies transmission, China, 2013. Eurosurveillance 2014; 19: 33-49.
24. Dortmans JC, et al. Adaptation of novel H7N9 influenza A virus to human receptors. Scientific Reports 2013; 3: 3058.
25. Bowles NE, et al. Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions. Molecular Genetics & Genomic Medicine 2014; 2: 356-361.